SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc.
NNVC 1.985+19.6%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: donpat11/13/2015 1:07:31 PM
   of 12871
 
SARS-like Virus in Bats Could Jump to HumansLast Updated: November 12, 2015.





But, researchers don't know if virus could then spread from person-to-person




But, researchers don't know if virus could then spread from person-to-person.

THURSDAY, Nov. 12, 2015 (HealthDay News) -- A newly identified SARS-like virus in bats appears to be able to jump to humans without mutation, new research suggests.

However, it's not yet clear whether it would then be able to spread from person to person, the researchers said.

A worldwide outbreak of Severe Acute Respiratory Syndrome (SARS) in 2002-2003 was caused by a coronavirus that jumped from animals to humans. That outbreak resulted in 8,000 infections and nearly 800 deaths, the researchers noted.

"Studies have predicted the existence of nearly 5,000 coronaviruses in bat populations, and some of these have the potential to emerge as human pathogens," senior study author Ralph Baric, from the University of North Carolina at Chapel Hill, said in a university news release.

"So this is not a situation of 'if' there will be an outbreak of one of these coronaviruses, but rather when and how prepared we'll be to address it," Baric added.

Baric and his colleagues looked at how the SARS-like virus in Chinese horseshoe bats behaves. They found that it enters the bodies of bats and humans in the same way. The researchers also noted that this virus replicates as well as the SARS virus in primary human lung cells, the preferred target for infection.

There is no treatment for the newly discovered SARS-like virus, the researchers said.

The findings are important in light of ongoing debate over a U.S. government decision that considerably slows the development of vaccines or treatments for potentially dangerous coronaviruses, the researchers said.

Baric said "building resources, rather than limiting them, to both examine animal populations for new threats and develop therapeutics is key for limiting future outbreaks."

The study was published Nov. 9 in Nature Medicine.

More information

The U.S. Centers for Disease Control and Prevention has more about SARS.

SOURCE: University of North Carolina at Chapel Hill, news release, Nov. 10, 2015

doctorslounge.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext